Global Genital Herpes Treatment Market size was valued at US$ 5.42 Bn in 2022 and the total revenue is expected to grow at 4.3% through 2023 to 2029, reaching nearly US$ 7.28 Bn.Genital Herpes Treatment Market Overview:
Genital herpes is caused by the herpes simplex virus type HSV-2, which causes painful blisters around the vaginal areas in both men and women. Women have a higher risk of developing genital herpes than men. The herpes simplex virus has no effective cure. Blisters normally heal and disappear on their own, so treatment isn't always necessary. Genital Herpes is a contagious type of infection. Antiviral medications for herpes can help limit outbreaks, relieve discomfort, and prevent symptoms from worsening. The antiviral medication is most successful if started during the first five days of the onset of symptoms.To know about the Research Methodology :- Request Free Sample Report
Market Dynamics:
According to research published by the WHO (World Health Organization) in 2017, the herpes virus HSV-1 was detected in roughly 3.7 billion people under the age of 50 around the world. Besides, the herpes virus HSV-2 has been detected in about 417 million persons worldwide between the ages of 11 and 49. In the future years, the increased incidence of the herpes simplex virus is expected to propel growth in the global genital herpes treatment market. Patients diagnosed with herpes usually lean on medicine to reduce the symptoms of the virus since herpes is a persistent condition with no permanent cure. This opens up numerous chances for vendors and manufacturers in the global genital herpes treatment market to develop effective, long-lasting treatments. Rising global awareness of the incidence and severity of sexually transmitted infections (STIs) as well as treatment choices for various STIs are some of the important reasons driving the global genital herpes treatment market forward shortly. Companies are ramping up clinical trials for a genital herpes vaccine in order to improve genital herpes prevention and treatment. Geneva is working on genital herpes vaccinations and conducting a clinical trial of GEN-003. It could be the first therapeutic vaccine for a chronic illness and the first advancement in genital herpes treatment in more than 20 years. GEN-003 is experimental immunotherapy for the treatment of genital herpes infections that have reached Phase 3. The market for genital herpes therapy will grow as a result of these new advancements, particularly in Western Europe.Genital Herpes Treatment Market Segment Analysis:
The Acyclovir segment is dominating the Type of Drug segment of the Global Genital Herpes Treatment Market: Acyclovir is a popular first-line antiviral drug that is predicted to hold a sizable market share over the forecast period. Antivirals used to treat herpes infection, such as valacyclovir, are also used to treat genital herpes. Moreover, Acyclovir is a typical drug that speeds up the healing of the sores and decreases symptoms such as pain, tingling, burning, and itching. Moreover, this drug belongs to the category of Antivirals. Acyclovir is also used in the treatment of cold sores, shingles, and chickenpox. Further, common side effects of Acyclovir include nausea, diarrhea, and partially severe side effects include renal failure, low platelet count hence, these side effects can hamper the growth of the Acyclovir segment. Acyclovir is considered safe in pregnant women with no harm to the fetus and is available in both oral formulations as well as parenteral in the market. The Retail pharmacy segment is considered to supplement the growth of the Genital Herpes Treatment Market. The retail pharmacy segment had the largest market share of 49.3% in the year 2022 and is anticipated to grow at a CAGR of 4.7% during the forecast period. The key factor attributing to the growth of the market is the presence of a generic market. The most prevalent cause of genital herpes is a rise in the number of people suffering from lifestyle-related illnesses include stress, sedentary lives, and bad eating habits, unhygienic routine. This will assist the global retail pharmacy market to grow by regulating medication on an ongoing basis. This will further make prescription-based drugs mandatory, which would help the worldwide pharmacy retail business to grow. Hence, these factor is likely to lift the growth of global genital herpes treatment market during the forecast period. The growth is further supported by the online pharmacy due to the Covid-19 pandemic and implementations of lockdown all over the world. Further, the doorstep service offered by the online pharmacy is a key factor contributing to the market expansion.Regional Insights:
North America is estimated to grab larger market attention in the global Genital Herpes treatment Market. The global genital herpes treatment market is dominated by North America. During the projection period, the region is expected to be a very promising market for STD medications. The increased prevalence of the condition and the high cost of medications are likely to hamper the region's dominance. Further due to the significant consumption of antiviral medications in North America, the region is projected to remain the most important market. The demand for genital herpes treatment is anticipated to continue and is backed by the surge in sales of medications in ruling countries such as the US., and Canada. Further, increasing the productions of antiviral drugs in the region is estimated to propel the growth of the regional market, and the presence of market players such as GlaxoSmithKline, Dr reddy’s Laboratories Ltd., is further anticipated to support the growth of the market. The expanding world's aging population has a direct impact on medical systems, which would be necessary to fulfill the needs of the aging population. As a result, demand for antiviral medications, which may be used to treat a variety of viral infections, will rise. The objective of the report is to present a comprehensive analysis of the Global Genital Herpes Treatment Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Genital Herpes Treatment Market dynamics, structure by analyzing the market segments and project the Global Genital Herpes Treatment Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Genital Herpes Treatment Market make the report investor’s guide.Genital Herpes Treatment Market Scope: Inquire before buying
Genital Herpes Treatment Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 5.42 Bn. Forecast Period 2023 to 2029 CAGR: 4.3% Market Size in 2029: US $ 7.28 Bn. Segments Covered: by Product Metallic Soap Thickener Non Soap Thickener Inorganic Thickener Others by Type Power Generation Automotive Heavy Equipment Food & Beverages Metallurgy Genital Herpes Treatment Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina and Rest of South America)Genital Herpes Treatment Market Key Players are:
1. GlaxoSmithKline 2. Teva Pharmaceuticals Inc. 3. Mylan Pharmaceuticals Inc. 4. Apotheca Inc. 5. Sandoz Inc. 6. Novartis AG 7. Hospira Inc. 8. Novopharm Ltd. 9. Dr. Reddy’s Laboratories Ltd. 10.Abbott Laboratories 11.Sun Pharmaceuticals Industries Ltd 12.Valeant Pharmaceuticals International Inc. etc. 13.Bausch Health Companies Inc. 14.Cipla Inc. 15.Eli Lilly and Co. 16.Gilead Sciences Inc.FAQs:
1. What is the global Genital Herpes Treatment market value in 2022? Ans: Global Genital Herpes Treatment market value in 2022 was estimated as USD 5.42 Billion. 2. What is the global Genital Herpes Treatment market growth? Ans: The global Genital Herpes Treatment market is anticipated to grow with a CAGR of 4.3% in the forecast period and is likely to reach USD 7.28 Billion by the end of 2029. 3. Which Distribution Channel segment is expected to dominate the global Genital Herpes Treatment market during the forecast period? Ans: The Retail Pharmacy segment is projected to lead the market growth and held the largest market share of 49.3% in 2022. The key factor attributing to the growth of the market is the presence of a generic market. 4. Who are the key players in the Genital Herpes Treatment market? Ans: Some key players operating in the market include Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd and Abbott Laboratories are the top five companies operating in the market 5. What is the key driving factor for the growth of the global Genital Herpes Treatment market? Ans: Key factors that are driving the market growth include increasing demand for genital herpes treatment due to rising cases of genital herpes in countries such as China, India, Japan, and various others.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Genital Herpes Treatment Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Genital Herpes Treatment Market 3.4. Geographical Snapshot of the Genital Herpes Treatment Market, By Manufacturer share 4. Global Genital Herpes Treatment Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Genital Herpes Treatment Market 5. Supply Side and Demand Side Indicators 6. Global Genital Herpes Treatment Market Analysis and Forecast, 2022-2029 6.1. Global Genital Herpes Treatment Market Size & Y-o-Y Growth Analysis. 7. Global Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 7.1.1. Acyclovir 7.1.2. Famciclovir 7.1.3. Valacyclovir 7.1.4. Others 7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 7.2.1. Hospitals 7.2.2. Retail pharmacy 7.2.3. Online pharmacy 8. Global Genital Herpes Treatment Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 9.1.1. Acyclovir 9.1.2. Famciclovir 9.1.3. Valacyclovir 9.1.4. Others 9.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 9.2.1. Hospitals 9.2.2. Retail pharmacy 9.2.3. Online pharmacy 10. North America Genital Herpes Treatment Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 12. Canada Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 13. Mexico Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 14. Europe Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 15. Europe Genital Herpes Treatment Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 17. France Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 18. Germany Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 19. Italy Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 20. Spain Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 21. Sweden Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 22. CIS Countries Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 23. Rest of Europe Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 24. Asia Pacific Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 25. Asia Pacific Genital Herpes Treatment Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 27. India Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 28. Japan Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 29. South Korea Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 30. Australia Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 31. ASEAN Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 32. Rest of Asia Pacific Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 33. Middle East Africa Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 34. Middle East Africa Genital Herpes Treatment Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 36. GCC Countries Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 38. Nigeria Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 39. Rest of ME&A Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 40. South America Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 41. South America Genital Herpes Treatment Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 43. Argentina Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 44. Rest of South America Genital Herpes Treatment Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Type of Drug, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Genital Herpes Treatment Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Novartis AG 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. GlaxoSmithKline 45.3.3. Teva Pharmaceuticals Inc. 45.3.4. Mylan Pharmaceuticals Inc. 45.3.5. Apotheca Inc. 45.3.6. Sandoz Inc. 45.3.7. Hospira Inc. 45.3.8. Novopharm Ltd. 45.3.9. Dr. Reddy’s Laboratories Ltd. 45.3.10. Abbott Laboratories 45.3.11. Sun Pharmaceuticals Industries Ltd 45.3.12. Valeant Pharmaceuticals International Inc. etc. 45.3.13. Bausch Health Companies Inc. 45.3.14. Cipla Inc. 45.3.15. Eli Lilly and Co. 45.3.16. Gilead Sciences Inc 46. Primary Key Insights